Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Vella

Showing results (41-50 of 158) with videos related to

Pageof 16
Sort By:
Pharmacoeconomics|November 1, 2018
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER DataAndrea Marcellusi, Raffaella Viti, Loreta A Kondili, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2025
Increased risk of neuropsychiatric adverse events with dolutegravir-based antiretroviral therapy during pregnancy: Findings from a prospective cohort studyHadijja Namwase, Jackson K Mukonzo, Collins Ankunda, et al.
AIDS (London, England)|March 8, 2005
Mode of infant feeding and HIV infection in children in a program for prevention of mother-to-child transmission in UgandaMichele Magoni, Luciana Bassani, Pius Okong, et al.
Mitochondrion|November 11, 2009
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis modelStefano Loizzo, Massimo Pieri, Alberto Ferri, et al.
Journal of Medical Virology|April 19, 2005
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAARTEmanuele Nicastri, Antonio Chiesi, Claudio Angeletti, et al.
Therapeutic Delivery|July 25, 2012
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamicsFlavia Franconi, Ciriaco Carru, Ilaria Spoletini, et al.
AIDS (London, England)|April 2, 2005
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapyEmanuele Nicastri, Claudio Angeletti, Lucia Palmisano, et al.
Immunology Letters|November 18, 2005
Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patientsGabriella d'Ettorre, Mauro Andreotti, Martina Carnevalini, et al.
Igiene E Sanita Pubblica|July 23, 2003
[DREAM project early results (drug resources enhancement against AIDS in Mozambique)]Maria Cristina Marazzi, Leonardo Palombi, Leonardo Emberti Gialloreti, et al.
HIV Clinical Trials|July 11, 2007
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-upGabriella d'Ettorre, Lorenzo Zaffiri, Giancarlo Ceccarelli, et al.
Pageof 16

Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Pharmacoeconomics|November 1, 2018
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER DataAndrea Marcellusi, Raffaella Viti, Loreta A Kondili, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2025
Increased risk of neuropsychiatric adverse events with dolutegravir-based antiretroviral therapy during pregnancy: Findings from a prospective cohort studyHadijja Namwase, Jackson K Mukonzo, Collins Ankunda, et al.
AIDS (London, England)|March 8, 2005
Mode of infant feeding and HIV infection in children in a program for prevention of mother-to-child transmission in UgandaMichele Magoni, Luciana Bassani, Pius Okong, et al.
Mitochondrion|November 11, 2009
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis modelStefano Loizzo, Massimo Pieri, Alberto Ferri, et al.
Journal of Medical Virology|April 19, 2005
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAARTEmanuele Nicastri, Antonio Chiesi, Claudio Angeletti, et al.
Therapeutic Delivery|July 25, 2012
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamicsFlavia Franconi, Ciriaco Carru, Ilaria Spoletini, et al.
AIDS (London, England)|April 2, 2005
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapyEmanuele Nicastri, Claudio Angeletti, Lucia Palmisano, et al.
Immunology Letters|November 18, 2005
Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patientsGabriella d'Ettorre, Mauro Andreotti, Martina Carnevalini, et al.
Igiene E Sanita Pubblica|July 23, 2003
[DREAM project early results (drug resources enhancement against AIDS in Mozambique)]Maria Cristina Marazzi, Leonardo Palombi, Leonardo Emberti Gialloreti, et al.
HIV Clinical Trials|July 11, 2007
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-upGabriella d'Ettorre, Lorenzo Zaffiri, Giancarlo Ceccarelli, et al.
Pageof 16